FCM
BDSX icon

Farallon Capital Management’s Biodesix BDSX Stock Holding History

Farallon Capital Management’s Portfolio BDSX Stock Details BDSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-6,400
Closed -$36.1K – 150
2025
Q2 		$36.1K Sell
6,400
-86,565
-93% -$699K ﹤0.01% 142
2025
Q1 		$1.16M Sell
92,965
-97,606
-51% -$1.87M 0.01% 92
2024
Q4 		$5.83M Sell
190,571
-41,269
-18% -$1.21M 0.03% 86
2024
Q3 		$8.25M Buy
231,840
+137,931
+147% +$4.74M 0.04% 88
2024
Q2 		$2.87M Buy
+93,909
New +$2.68M 0.01% 99

Other funds holding BDSX

TAM
Telemark Asset Management Boston, Massachusetts $1.08B AUM 70.88% 1-Year Est. Return
BC
Birchview Capital Burlington, Vermont $176M AUM 95.04% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
MIM
Monashee Investment Management Boston, Massachusetts $184M AUM 197.43% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $107M AUM 82.62% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $980M AUM 470.8% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Farallon Capital Management's BDSX Position: Q3 2025 in Review

Farallon Capital Management sold out of Biodesix (BDSX) in Q3 2025, closing a stake of 6,400 shares — an estimated $36.1K sold.

Farallon Capital Management first reported a position in BDSX in Q2 2024 and held it in 5 quarters. The position peaked at $8.25M in Q3 2024. 26 funds tracked by Wall St. Rank hold BDSX as of Q3 2025.

  • Farallon Capital Management reported no remaining Biodesix position as of Q3 2025 after selling out during the quarter.
  • Farallon Capital Management sold 6,400 Biodesix shares in Q3 2025, an estimated $36.1K.
  • Farallon Capital Management first reported a position in Biodesix in Q2 2024 and held it in 5 quarters.
  • Farallon Capital Management's Biodesix position peaked at $8.25M in Q3 2024.
  • 26 funds tracked by Wall St. Rank held Biodesix as of Q3 2025.

Based on Farallon Capital Management's 13F filing for Q3 2025, filed 14 Nov 2025.